AB 1002 — Center for Cannabis Research.

Summary

(1) Existing law authorizes the creation by the University of California of the California Cannabis Research Program, the purpose of which is to develop and conduct studies intended to ascertain the general medical safety and efficacy of cannabis and, if found valuable, to develop medical guidelines for the appropriate administration and use of cannabis. Existing law authorizes the program to conduct focused controlled clinical trials on the usefulness of cannabis in patients diagnosed with specified conditions, including cancer and glaucoma. This bill would expand the purview of the program to include the study of naturally occurring constituents of cannabis and synthetic compounds that have effects similar to naturally occurring cannabinoids. The bill would authorize the program to cultivate cannabis to be used exclusively for research purposes and to contract with a private entity to provide expertise in cultivating medical cannabis. The bill would also authorize the controlled clinical trials to focus on examining testing methods for detecting harmful contaminants in cannabis, including mold and bacteria. (2) Existing law requires the President of the University of California, if the program is implemented, to appoint a multidisciplinary Scientific Advisory Council, not to exceed 15 members, to provide policy guidance in the creation and implementation of the program. This bill would require the president to appoint the advisory council on the advice of the director of the program. The bill would also require the program, by July 1, 2018, to report to the Legislature, the Governor, and the Attorney General on the progress of the cannabis studies and to report every year thereafter to the Legislature detailing the progress of the studies. (3) Existing law, the Control, Regulate and Tax Adult Use of Marijuana Act (AUMA) , an initiative statute approved by the voters at the November 8, 2016, statewide general election as Proposition 64, among other things, establishes the California Marijuana Tax Fund as a continuously appropriated fund consisting of specified taxes, interest, penalties, and other amounts imposed by AUMA. AUMA requires, after other specified disbursements are made from the fund, the Controller to disburse the sum of $10,000,000 annually to a public university or universities in California, beginning with the 2018–19 fiscal year until the 2028–29 fiscal year, to research and evaluate the implementation and effect of AUMA and, if appropriate, make recommendations to the Legislature and the Governor regarding possible amendments to AUMA. Existing law requires the Bureau of Marijuana Control to select the universities to be funded. This bill would provide that it is the intent of the Legislature that the state commission objective scientific research by the University of California under the California Cannabis Research Program to study the implementation and effect of the Control, Regulate and Tax Adult Use of Marijuana Act. The bill would also amend the provisions of AUMA to require the Bureau of Marijuana Control to consider selecting the University of California and the California Cannabis Research Program when selecting a public university or public universities to be funded to research and evaluate the implementation and effect of AUMA. This bill would also make conforming changes to a related provision of law. (4) AUMA authorizes legislative amendment of its provisions with a 23 vote of both houses of the Legislature, without submission to the voters, to further its purposes and intent. This bill would declare that its provisions further specified purposes and intent of the Control, Regulate and Tax Adult Use of Marijuana Act.

Bill Text

• Amended 07/18/17 - Amended Senate Current pdf July 18, 2017
• Amended 04/19/17 - Amended Assembly pdf April 19, 2017
• Amended 04/06/17 - Amended Assembly pdf April 06, 2017
• Introduced 02/16/17 - Introduced pdf February 16, 2017
• AB1002 View text html

Action History

1. September 01, 2017

   In committee: Held under submission.

2. August 21, 2017

   In committee: Referred to APPR. suspense file.

3. July 18, 2017

   From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on APPR.

4. June 13, 2017

   From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (June 12). Re-referred to Com. on APPR.

5. May 24, 2017

   Referred to Com. on B., P. & E.D.

6. May 11, 2017

   In Senate. Read first time. To Com. on RLS. for assignment.

7. May 11, 2017

   Read third time. Passed. Ordered to the Senate. (Ayes 77. Noes 0. Page 1490.)

8. May 04, 2017

   Read second time. Ordered to Consent Calendar.

9. May 03, 2017

   From committee: Do pass. To Consent Calendar. (Ayes 16. Noes 0.) (May 3).

10. April 26, 2017

    From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (April 25). Re-referred to Com. on APPR.

11. April 20, 2017

    Re-referred to Com. on B. & P.

12. April 19, 2017

    From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended.

13. April 17, 2017

    Re-referred to Com. on B. & P.

14. April 06, 2017

    From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended.

15. March 27, 2017

    Referred to Com. on B. & P.

16. February 17, 2017

    From printer. May be heard in committee March 19.

17. February 16, 2017

    Read first time. To print.

Sponsors

• Cooley · Primary
• Tom Lackey · Cosponsor

Votes

Subjects